Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KANSL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PROM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PCDHA8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | PHOSPHO2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | KIAA1462 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SUGP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CASP9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | NPM1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | COX10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ASB7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |